Thank you This live web event has ended. Thank you for attending. Contributors Jim Fink (Aerogen Pharma) Currently Chief Science Officer for Aerogen Pharma Corporation and Sr. Fellow Clinical Aerosol Product Development for Dance Biopharm Inc., Brisbane, CA., Prior to 2015, Jim was an Independent Consultant serving the biotech industry, and Chief Clinical Officer for Aerogen Ltd, Galway, Ireland, Dr. Fink is an Adjunct Professor for the Respiratory Therapy Program at GA State University in Atlanta, Rush Medical School in Chicago, and Visiting Professor, Department of Physical therapy, Universidade Federal de Pernambuco, Recife, Brazil. He has a PhD in Pharmaceutical Innovation from Bradford University, UK. A strong patient care advocate, he served as Chair for the Chicago Asthma Consortium. Jim has authored several textbooks, multiple chapters, reviews and original research concerning use of medical aerosols. He is a member of the International Society of Aerosols in Medicine, Society of Critical Care Medicine, European Respiratory Society, American Thoracic Society and a Fellow of the American Association for Respiratory Care and the American College of Chest Physicians. Dr. Fink serves on the editorial board for the Journal of Aerosol Medicine and Pulmonary Drug Delivery, Inhalation and serves on the ISAM board. Dr. Fink was awarded the 2017 Forest M. Bird Lifetime Scientific Achievement award from the American Respiratory Care Foundation.